Article
Inhibition of epidermal growth factor receptor tyrosine kinase fails to suppress adenoma formation in ApcMin mice but induces duodenal injury.
Cancer research - 1 Sept 2000
Ritland S R, Gendler S J, Burgart L J, Fry D W, Nelson J M, Bridges A J, Andress L, Karnes W E
Abstract excerpt
A highly selective, p.o. bioavailable irreversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, N-[4-(3-chloro4-fluorophenylamino)-quinazolin-6-yl]-ac rylamide (CFPQA), was evaluated for its ability to prevent intestinal adenoma formation in ApcMin mice. Ten-week continuous dietary exposure to CFPQA at doses sufficient to abolish intestinal EGFR tyrosine phosphorylation failed to affect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
